Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib in methotrexate-naive early rheumatoid arthritis with MRI endpoints
2010-020890-18Phase 2Completed
- Sponsor
- Pfizer
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tofacitinib in rheumatoid arthritis (RA) (3 arms), sponsored by Pfizer. Primary endpoints: Change from baseline in wrist and metacarpophalangeal bone marrow edema at Month 6 and Change from baseline in wrist and metacarpophalangeal synovitis at Month 3. Started Nov 2010; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2010-020890-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020890-18.